Literature DB >> 114566

Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea.

T Nencioni, A Miragoli, F Dorato, F Polvani.   

Abstract

Two euprolactinemic women with hypothalamic amenorrhea, previously unsuccessfully submitted to clomiphene citrate therapy, were treated with bromocriptine. PRL secretion was studied in basal conditions and under dynamic tests: TRH and chlorpromazine. Serum FSH, LH and 17-beta-estradiol were determined before and during the treatment. Both patients conceived, and one delivered a healthy baby at term. Bromocriptine appears to be an effective drug for treating women with hypothalamic amenorrhea, particularly those unresponsive to clomiphene.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 114566     DOI: 10.1007/BF03346772

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  6 in total

1.  Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.

Authors:  R P Dickey; S C Stone
Journal:  Obstet Gynecol       Date:  1976-07       Impact factor: 7.661

2.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

3.  The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

Authors:  E Del Pozo; R B Del Re; L Varga; H Friesen
Journal:  J Clin Endocrinol Metab       Date:  1972-11       Impact factor: 5.958

4.  Radioimmunoassay of oestrone and oestradiol in human plasma.

Authors:  Y Emment; W P Collins
Journal:  Acta Endocrinol (Copenh)       Date:  1972-03

5.  Induction of menstruation with bromocryptine in patients with euprolactinemic amenorrhea.

Authors:  G Tolis; F Naftolin
Journal:  Am J Obstet Gynecol       Date:  1976-10-15       Impact factor: 8.661

6.  Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.

Authors:  E Del Pozo; L Varga; H Wyss; G Tolis; H Friesen; R Wenner; L Vetter; A Uettwiler
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.